Literature DB >> 2468883

Potential-dependent interactions of nitrendipine and related 1,4-dihydropyridines in functional smooth muscle preparations.

D J Triggle1, M Hawthorn, W Zheng.   

Abstract

Interaction of nitrendipine and other Ca2+ channel antagonists including nifedipine, diltiazem, and D600 with intestinal smooth muscle was shown to depend on membrane potential. In the absence of extracellular Ca2+, guinea pig ileal longitudinal muscle does not contract and can be incubated at various K+ concentrations in the presence or absence of antagonist. Preincubation with elevated K+ prior to admission of Ca2+ and challenge with K+ to a total of 100 mM increased the activity of the antagonist. The IC50 for nitrendipine incubated in the presence of 5 mM K+ was 5.36 X 10(-9) M and in the presence of 40 mM K+ was 0.53 X 10(-9) M. Other 1,4-dihydropyridines showed similar potency shifts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2468883     DOI: 10.1097/00005344-198806124-00018

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Comparative studies of AJG049, a novel Ca2+ channel antagonist, on voltage-dependent L-type Ca2+ currents in intestinal and vascular smooth muscle.

Authors:  M Hashimoto; N Teramoto; H-L Zhu; K Takahashi; Y Ito
Journal:  Br J Pharmacol       Date:  2006-08-14       Impact factor: 8.739

2.  The effects of nifedipine on alpha 2-adrenoceptor-mediated contractions in several isolated blood vessels from the rabbit.

Authors:  W R Dunn; C J Daly; J C McGrath; V G Wilson
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

3.  Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.

Authors:  N Morel; T Godfraind
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

4.  Binding sites for 1,4-dihydropyridine Ca(2+)-channel modulators in rat intestinal smooth muscle.

Authors:  S Salomone; M Wibo; N Morel; T Godfraind
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.